Govee Presents Sanctuary, Reimagining the Modern Home Through Floor Lamps, Colour and Design
Created with celebrity interior designer Fawn Galli, the one-night showcase introduced Govee's latest Floor Lamp Series through styled home settings A panel discussion explored how lighting, colour and design can help homes feel more flexible,...
Bambusa Therapeutics Presents Positive Preliminary Phase 1 BBT002 Data at American Thoracic Society 2026 (ATS 2026) International Conference and Announces First Patient Dosed in Phase 1b/2a CRSwNP Trial
- BBT002 is a next-generation, long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-5 - - Preliminary Phase 1 data demonstrated rapid, deep, and sustained effects on key biomarkers for at least 8...
Linglong Tire Presents Sustainable Concept Tire at World Business Council for Sustainable Development
MONTREUX, Switzerland, May 7, 2026 /PRNewswire/ -- From April 27-28, 2026, the World Business Council for Sustainable Development (WBCSD) Annual Meeting was held in Montreux, Switzerland. This premier global sustainability forum gathered nearly 600...
MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026
GUANGZHOU, China, May 6, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II clinical...
D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types
Elisrasib monotherapy demonstrates notable efficacy in three major tumor types at its recommended phase 2 dose (RP2D , 600 mg QD). Phase 2 clinical outcomes include: 2L+ KRAS G12Ci–naive NSCLC: ORR of 58.8%, mPFS of 12.2 months 2L+ colorectal cancer...
Infinitus Presents Human Evidence-Based Research Findings at FFC 2026
GUANGZHOU, China, April 30, 2026 /PRNewswire/ -- Ma Jun, Vice President and Chief Science Innovation Officer of Infinitus (China) Company Ltd., was invited to attend the Functional Food Conference 2026 (FFC 2026), held recently in Hangzhou, Zhejiang...
Minister K Shanmugam Presents AmCham CARES Awards to companies at the AmChamSG 53rd Annual General Meeting and Social Impact Fair
Annual ceremony recognizes a record number of SMEs for their CSR contributions SINGAPORE, April 27, 2026 /PRNewswire/ --The American Chamber of Commerce in Singapore (AmChamSG) marked the 10th anniversary of its Corporate and Social Action:...
Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
- Participants achieving HBsAg loss with pegylated interferon alfa (PEG-IFNα) ± elebsiran or BRII-179 demonstrated favorable off-treatment clinical outcomes, with most HBsAg rebounds <10 IU/mL and HBV DNA rebound infrequent and not associated...
Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
High Impact Session presented at Heart Rhythm Society's Congress in Chicago First time showing results of new Less Invasive approach Improvement in Left Ventricular Ejection Fraction (LVEF), 6 Minute Walk Test (6MWT), Quality of Life (QOL) and New...
Kia Presents Vision Meta Turismo at Milan Design Week, Redefining the Grand Tourer for the Digital Age
Vision Meta Turismo concept embodies Kia's futuristic approach to a new era of electric mobility, offering a more dynamic, engaging, and visceral driving experience Contemporary reinterpretation of three core experiences: performance driving,...